MINNEAPOLIS -- CNS, Inc. (NASDAQ:CNXS) today announced that the waiting period required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the proposed acquisition of the Company by merger with a subsidiary of GlaxoSmithKline plc ( GSK ) terminated at midnight on November ...